DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 5.80 0.28%
market minute promo

103.21 0.87 (0.85%)

REAL-TIME: Last trade at

Extended Hours: $103.26 $0.01 (0.01%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

SLXP $103.21 0.85%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $102.29
Previous Close $102.34
Daily Range $101.47 - $103.45
52-Week Range $82.52 - $172.98
Market Cap $6.6B
P/E Ratio -81.94
Dividend (Yield) $0.00 (0.0%)
Volume 962,089
Average Daily Volume 3,163,809
Current FY EPS -$1.19





Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website:

News & Commentary

Why Salix Pharmaceuticals Ltd. Stock Was Throttled

Salix Pharmaceuticals is today's biggest loser after the company swung and missed badly on its third-quarter earnings results and fourth-quarter guidance.

Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews

How Adam Feuerstein Follows The Biotech Sector

Actavis Says 'Let's Make A Deal'

Salix Pharmaceuticals: What Scares Me Most About Its High Inventory & Stock Collapse

Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog

Salix Crashes on Inventory Issues, Lowered Outlook - Analyst Blog

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection

Deutsche Bank Slashes Price Target On Salix Pharmaceuticals

Trade-Ideas: Salix Pharmaceuticals (SLXP) Is Today's "Dead Cat Bounce" Stock

Salix Pharmaceuticals (SLXP) Downgraded From Buy to Hold

See More SLXP News...

SLXP's Top Competitors

SLXP $103.21 (0.85%)
Current stock: SLXP
NVS $95.56 (0.55%)
Current stock: NVS
PFE $31.10 (2.07%)
Current stock: PFE
RHHBY $37.41 (0.54%)
Current stock: RHHBY